Inspira™ Technologies will Reveal the New ALICE™ Device at the World’s Largest Extracorporeal Life Support Conference

0
112

Summation

  • IINN, IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, has announced today it will reveal the new ALICETM device at the world’s largest Extracorporeal Life Support Organization (ELSO) conference, the 34th Annual ELSO Conference in Seattle, Washington, which will be held between the 28th of September and the 1st of October 2023.
  • Inspira is on track with plans in the coming months to submit the ALICE medical device to the U.
  • “Revealing the ALICE medical device to the medical community at the ELSO conference in the U.

Inspira™ Technologies OXY B.H.N. Ltd(Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”), a company aiming to revolutionize acute respiratory care, has announced today it will reveal the new ALICETM device at the world’s largest Extracorporeal Life Support Organization (ELSO) conference, the 34th Annual ELSO Conference in Seattle, Washington, which will be held between the 28th of September and the 1st of October 2023.

“Revealing the ALICE medical device to the medical community at the ELSO conference in the U.S. marks an important milestone for the company and the first step towards Inspira’s market penetration. At the conference we plan to initiate commercial engagements,” commented Joe Hayon, President of Inspira Technologies.

The ALICE is an extracorporeal blood circulation medical device allowing for cardiac and pulmonary support. During the extracorporeal treatment, the ALICE device is designed to provide continuous enrichment of the blood with oxygen and carbon dioxide removal. The device is designed with an innovative user interface and unique features aimed to facilitate and enhance user experience. Inspira is on track with plans in the coming months to submit the ALICE medical device to the U.S. Food and Drug Administration under the 510(k) pathway.

About ELSO

The Extracorporeal Life Support Organization (ELSO) is an international nonprofit consortium of health care institutions, researchers, and industry partners. The organization provides support to those delivering extracorporeal life support through continuing education, guidelines, original research, publications, and a comprehensive registry of extracorporeal membrane oxygenation (ECMO) patient data. ECMO clinicians, research scientists, and members of regulatory and public health institutions are eligible for membership in ELSO. There are currently over 20,000 users and center members from over 50 countries. Memberships allows physicians, nurses, perfusionists, respiratory therapists, researchers and other healthcare professionals to become more directly involved in the world’s largest ECMO community.